Skip to content

Characteristics of serum microRNA expression in patients who benefit from acupuncture treatment of diminished ovarian reserve

Characteristics of serum microRNA expression in patients who benefit from acupuncture treatment of diminished ovarian reserve

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2025000004
Enrollment
Unknown
Registered
2025-01-03
Start date
2025-01-07
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diminished ovarian reserve

Interventions

Acupuncture group:Acupuncture
Ineffective cases in the acupuncture group:Acupuncture
Effective cases in the acupuncture group:Acupuncture

Sponsors

Institute of Acupuncture and Moxibustion China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
22 Years to 40 Years

Inclusion criteria

Inclusion criteria: (1) Meet the diagnostic criteria of DOR; (2) Female 22 years old= age < 40 years old; (3) Voluntarily participate in the trial and sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1)FSH=25 IU/L (2) Polycystic ovary syndrome uncontrolled hyperprolactinemia hypothyroidism and other diseases that affect ovulation; (3) POA caused by iatrogenic factors (such as pelvic surgery chemoradiotherapy uterine artery embolization drugs such as hormones immunosuppressants etc.); (4) karyotypic abnormalities; (5) Patients with severe cardiovascular and cerebrovascular hepatic kidney malignant tumors hematopoietic system and mental diseases.

Design outcomes

Primary

MeasureTime frame
microRNA;Antral Follicle Counting;

Secondary

MeasureTime frame
Estradiol;Luteinizing Hormone;Clinical pregnancy rate;Follicle Stimulating Hormone;anti-Müllerian hormone;Number of eggs retrieved;

Countries

China

Contacts

Public ContactHuanfang Xu

Institute of Acupuncture and Moxibustion China Academy of Chinese Medical Sciences

huanfang_xu@126.com15711082019

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026